Author

François Audhuy

Observed names: F. Audhuy, Francois Audhuy

Institution: Merck Serono S.A.S. (France)

Observed institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Seoul National University, Merck KGaA, Darmstadt (Germany), Seoul National University Hospital, Merck Serono S.A.S. (France), EMD Serono, Inc. (United States), National Taiwan University Hospital, Merck Healthcare KGaA, Darmstadt (Germany)

OpenAlex ID: A5112235686

Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation

2017 · Robert L. Ferris, Heinz-Josef Lenz, et al. · Cancer Treatment Reviews · 190

Dual inhibition of TGF‐β and PD‐L1: a novel approach to cancer treatment

2021 · James L. Gulley, Jeffrey Schlom, et al. · Molecular Oncology · 176

Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1–High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial

2023 · Byoung Chul Cho, Jong Seok Lee, et al. · Journal of Thoracic Oncology · 98

Polypeptide composition of an adenovirus type 5 used in cancer gene therapy

2001 · Francis Blanche, Bertrand Monegier, et al. · Journal of Chromatography A · 31

Bintrafusp alfa and chemotherapy as first-line treatment in biliary tract cancer: A randomized phase 2/3 trial

2024 · Do-Youn Oh, Masafumi Ikeda, et al. · Hepatology · 27

Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study

2023 · Everett E. Vokes, Francoise Mornex, et al. · Journal of Thoracic Oncology · 21

RAS mutation testing in patients with metastatic colorectal cancer in French clinical practice: A status report in 2014

2018 · Astrid Lièvre, Jean-Louis Merlin, et al. · Digestive and Liver Disease · 14

Treatment Patterns and Survival in Locally Advanced or Metastatic Biliary Tract Cancer Using SEER Medicare Data

2023 · Mark D. Danese, Kabir Mody, et al. · Gastro Hep Advances · 13

MOMENT registry: Patients with advanced non-small-cell lung cancer harboring MET exon 14 skipping treated with systemic therapy

2025 · Michael Thomas, Petros Christopoulos, et al. · Journal of Comparative Effectiveness Research · 2

Évaluation en vie réelle des tests RAS chez des patients atteints d’un cancer colorectal métastatique

2016 · M. Ducreux, P. Artru, et al. · Revue d Épidémiologie et de Santé Publique

Works count: 10

Citation count: 572

H-index: 8

I10-index: 8